CogState has earned a solid reputation in scientific research for its standard and customized test batteries, as well as its reliable computerized testing systems and methods of analysis of cognitive data. It has proven itself as a leader in cognition testing and offers sponsor companies the most innovative and appropriate cognitive assessment strategies, including computerized testing, traditional paper and pencil batteries, such as the Neuropsychological Test Battery (NTB) developed by Dr. John Harrison, Principal Scientist for CogState Ltd. CogState clinical trials systems also include real-time data reporting programs which provide investigators with new opportunities for both immediate data read-out and monitoring data quality.
In response to the increasing focus on cognitive assessment within clinical trials, CogState sought out an established, global pharmaceutical services company with a proven methodology for ensuring data quality in clinical trials. "UBC's customized, hands-on approach to rater training, assessment and ongoing rater surveillance is a perfect fit with CogState's portfolio of evidence-based cognitive testing capabilities," said Brad O'Connor, CEO of CogState.
UBC's leading Ratings Services group is focused on standardizing the administration and scoring of clinically subjective outcome measures used as pivotal endpoints in clinical trials. Its data collection, data monitoring and training services are designed to reduce data variance and maximize inter-site reliability across countries. UBC has trained, certified and monitored more than 20,000 raters, testers and investigators in more than 60 countries encompassing over 400 protocols.
Catherine Spear, Senior Vice-President of UBC's Ratings Services group
|SOURCE United BioSource Corporation|
Copyright©2008 PR Newswire.
All rights reserved